News | August 13, 2023
Aurobindo Pharma reports Q1 FY24 consolidated PAT at Rs. 570.75 Cr
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
Krsnaa Diagnostics has reported total income of Rs. 143.80 crores during the period ended June 30, 2023
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023
IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023
The medical device sector is considered as one of the sunrise sectors in the country
The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
